Regulation of IL-10 expression by upstream stimulating factor (USF-1) in glioma-associated microglia

Leying Zhang1, Michelle Van Handel, Jill M Schartner

  • 1Department of Neurosurgery, Beckman Research Institute, City of Hope National Medical Center, CA 91010, USA.

Journal of Neuroimmunology
|February 10, 2007
PubMed

Insights

Tumor-associated microglia/macrophages (MG/MP) in brain tumors show suppressed immune responses. Down-regulation of USF-1 in MG/MP may contribute to increased IL-10, impacting tumor immunity.

Area of Science:

  • Neuroimmunology
  • Oncology
  • Molecular Biology

Background:

  • Malignant brain tumors necessitate understanding CNS immune responses for effective immunotherapy.
  • Tumor-associated microglia/macrophages (MG/MP) in glioma models exhibit reduced responsiveness to common immune activators.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying MG/MP suppression in the brain tumor microenvironment.
  • To investigate the role of specific nuclear factors in regulating MG/MP function within gliomas.

Main Methods:

  • Utilized rodent intracranial C6 glioma models.
  • Analyzed nuclear extracts from tumor-associated and normal MG/MP using Electrophoretic Mobility Shift Assay (EMSA).
  • Investigated IL-10 expression regulation via siRNA-mediated inhibition of USF-1 in primary MG/MP cultures.

Main Results:

  • Down-regulation of the nuclear factor USF-1 was observed specifically in tumor-associated MG/MP.
  • Tumor-associated MG/MP displayed higher expression of IL-10 compared to normal MG/MP.
  • Inhibition of USF-1 in MG/MP cultures led to increased IL-10 mRNA expression.

Conclusions:

  • USF-1 is down-regulated in MG/MP within the brain tumor microenvironment.
  • USF-1 may play a critical role in the regulation of IL-10 expression in MG/MP.
  • These findings offer insights into the immunosuppressive mechanisms in brain tumors and potential therapeutic targets.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...